Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K F Browne

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of the American College of Cardiology|July 1, 1995
Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplastyG W Stone, C L Grines, K F Browne, et al.
The Journal of Invasive Cardiology|April 4, 2000
Worse six-month outcome for patients with multiple stents in a single coronary arteryE Gaxiola, R E Vlietstra, K F Browne, et al.
Circulation|January 1, 1991
Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study InvestigatorsJ L Anderson, S G Sorensen, F L Moreno, et al.
Journal of the American College of Cardiology|April 1, 1997
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial InvestigatorsG W Stone, C L Grines, D Rothbaum, et al.
Journal of the American College of Cardiology|March 18, 1999
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trialC M Nunn, W W O'Neill, D Rothbaum, et al.
Journal of the American College of Cardiology|June 1, 1988
Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinaseJ L Anderson, R L Rothbard, R A Hackworthy, et al.
Journal of the American College of Cardiology|October 1, 1992
Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 InvestigatorsJ L Anderson, L C Becker, S G Sorensen, et al.
Circulation|August 1, 1996
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trialG L Schaer, L J Spaccavento, K F Browne, et al.
The American Journal of Cardiology|July 1, 1996
Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapyG W Stone, C L Grines, K F Browne, et al.
Catheterization and Cardiovascular Diagnosis|December 1, 1996
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) InvestigatorsG W Stone, C L Grines, K F Browne, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of the American College of Cardiology|July 1, 1995
Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplastyG W Stone, C L Grines, K F Browne, et al.
The Journal of Invasive Cardiology|April 4, 2000
Worse six-month outcome for patients with multiple stents in a single coronary arteryE Gaxiola, R E Vlietstra, K F Browne, et al.
Circulation|January 1, 1991
Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study InvestigatorsJ L Anderson, S G Sorensen, F L Moreno, et al.
Journal of the American College of Cardiology|April 1, 1997
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial InvestigatorsG W Stone, C L Grines, D Rothbaum, et al.
Journal of the American College of Cardiology|March 18, 1999
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trialC M Nunn, W W O'Neill, D Rothbaum, et al.
Journal of the American College of Cardiology|June 1, 1988
Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinaseJ L Anderson, R L Rothbard, R A Hackworthy, et al.
Journal of the American College of Cardiology|October 1, 1992
Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 InvestigatorsJ L Anderson, L C Becker, S G Sorensen, et al.
Circulation|August 1, 1996
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trialG L Schaer, L J Spaccavento, K F Browne, et al.
The American Journal of Cardiology|July 1, 1996
Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapyG W Stone, C L Grines, K F Browne, et al.
Catheterization and Cardiovascular Diagnosis|December 1, 1996
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) InvestigatorsG W Stone, C L Grines, K F Browne, et al.
Pageof 4